Avidity Biosciences is pioneering a new class of precision medicines – antibody-siRNA conjugates (ASC™) – to deliver nucleic acid therapeutics against genetic drivers of disease.  Our ASCs have drug-like properties similar to antibodies and antibody-drug conjugates.  Importantly, their unique siRNA-based “payloads” permit selective targeting of disease-associated mRNAs against virtually any target of interest.

Biotechnology

Education

Avidity

Avidity's headquarters in San Diego, CA, United States

Michael Cochran

Jennifer Perkins

Kat Lange

W. Michael Flanagan

Zachary Richardson

Ethan Lovell

Brendan Winslow

Lisa Brockman

Luis Estevez

Traci S.

Kerri Bobnar RN

Lynn Kator

Laura Genatossio

Annie Vanselow

Drew Robertson

Lynne Pratt

Jennifer Rivera

Ashish Dhawan

Michelle A.

Joseph Johnston

Charles Calderaro III

Tim Buck

Carmen Castrillo-Viguera

Gautam Nayar

Gulin Erdogan

Eileen Blasi

Betania Glorio

Jason J.

Lisa Kanetake

Qing Chang M.d.

Arthur A. Levin

Scott Hager

Steve Hughes

Hanhua Huang

Andrew J. Geall

Zoë Adams

Christopher Gartshore

Anaïs Kervadec

Oluwaseyi Adekunle

Madilyne Malone

Johan van Beek

Beth Henriksen

Roger Furr

Carlos Bravo

Nicki Mendoza

Deidra Richards

Dani Tolley

Cheryl Crook (Domier), PHR

Todd McPherron

Ian Matthew

Ania W.

Kiyomi Hashizume Donnellan

Usue Etxaniz

Ernest Chow

Afshawn C.

Katie Jepsen

Anneke Raney

Carolyn Ball

Jerry Yu

Brian Laing

Edna Cheung

Ben Mead

Elizabeth Kinter

Chiara Troncatti

Maria Calkins

Yan Moore

Jason Cho

Katheryn Ramirez

Casandra Gil

Kristen Sullivan

Stephanie Huynh

Carsten Boess

Tamar Thompson

Noreen Henig

Edward Kaye

This department oversees the planning, execution, and management of clinical studies and data analysis to ensure effective product development and market access.

Clinical Development and Operations

This department conducts research and development to advance scientific knowledge and innovation.

Scientific Research

This department oversees all aspects of quality assurance and compliance to ensure products meet regulatory standards and internal guidelines.

Quality Assurance

The Clinical Operations Team at Avidity Biosciences manages the planning, execution, and oversight of clinical trials for ASC™ therapies. They ensure that clinical studies are conducted efficiently, ethically, and within regulatory guidelines, coordinating between various departments to collect, manage, and analyze clinical data. The team is also responsible for optimizing health economics and outcomes research to demonstrate the therapeutic value of ASC™ treatments.

Clinical Operations Team

This department focuses on conducting and analyzing research to support organizational goals and initiatives.

Research Department

The Scientific Research Team at Avidity Biosciences is dedicated to advancing the development of antibody-siRNA conjugates (ASC™). Comprising scientists specialized in toxicology, bioinformatics, drug discovery, and biomarkers, the team collaborates to design, synthesize, and validate innovative ASC therapies targeting disease-associated mRNAs. Their work involves rigorous experimentation, clinical evaluation, and the optimization of drug-like properties to advance precision medicine solutions for genetic diseases.

Scientific Research Team

Avidity

Org chart

Board & advisors

Teams

Clinical Development and Operations

Scientific Research

Quality Assurance

Clinical Operations Team

Research Department

Scientific Research Team

Offices

Avidity

Org chart

Board & advisors

Teams

Clinical Development and Operations

Scientific Research

Quality Assurance

Clinical Operations Team

Research Department

Scientific Research Team

Offices

Related companies